A detailed history of Harfst & Associates, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Harfst & Associates, Inc. holds 8,151 shares of DHR stock, worth $1.8 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
8,151
Previous 8,010 1.76%
Holding current value
$1.8 Million
Previous $1.58 Million 2.15%
% of portfolio
0.31%
Previous 0.34%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$181.46 - $212.2 $25,585 - $29,920
141 Added 1.76%
8,151 $1.62 Million
Q2 2025

Aug 12, 2025

BUY
$174.64 - $205.16 $822,903 - $966,713
4,712 Added 142.87%
8,010 $1.58 Million
Q1 2025

May 13, 2025

BUY
$201.62 - $250.59 $664,942 - $826,445
3,298 New
3,298 $676,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $160B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Harfst & Associates, Inc. Portfolio

Follow Harfst & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.